Clinical Trial: Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium

U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07427446) titled 'Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium' on Feb. 17.

Brief Summary: Fifty children undergoing heart catheterization without local anesthesia in the skin will be randomly divided into two groups.

Group DM (Dexmedetomidine + Midazolam) and Group KM (Ketamine + Midazolam)

Study Start Date: Feb. 01

Study Type: INTERVENTIONAL

Condition: Emergence Delirium

Intervention: DRUG: Dexmedetomidine and Midazolam

Children will receive Dexamedetomedine and Midazolam

DRUG: Ketamine and Midazolam

Children will receive Ketamine and Midazolam

Recruitment Status: RECRUITING

Sponsor: Kasr El Aini Hospital

Info...